Ekberg and colleagues proposed that in type 1 diabetes a deficiency of C peptide, a subunit of the proinsulin molecule, also contributes to nerve damage; their animal studies showed that C-peptide ...

Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...

Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the ...

your doctor may order additional tests such as antibody tests (to detect type 1 diabetes) or a C-peptide test (to measure insulin production)." These tests, along with your medical history and ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...

Citi referred to the data as a "major scientific advance" for type 1 diabetes patients ... evidenced by circulating C-peptide levels, which indicate insulin production. Additionally, a mixed ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

Short sleep and frequent snoring linked to greater type 2 diabetes risk in women with a history of gestational diabetes.